February 23, 2011, Montréal, Canada – After 5 years of operations and growth, Vantage BioTrials has successfully concluded four client audits of their systems, SOPs and Good Clinical Practices. The audits occurred over a span of 2 months and each resulted in minor findings. All Sponsor comments, feedbacks and observations were addressed and resolved.

“We always remain open to constructive feedback from our clients and dedicated to the highest expectations of quality in the delivery of our services,” says Vahe Bartekian, Vice-President of Quality Management. “As a relatively young CTMO, we are extremely proud and remain dedicated to delivering quality services to our Clients. We are looking forward to proving ourselves with each new project that comes our way.”

About Vantage BioTrials Inc.

Vantage BioTrials Inc. is a privately owned Clinical Trial Management Organization (CTMO) based in Montréal Canada that provides superior trial management services and combines a precise blend of clinical development knowledge, talent and resources that will ensure a clinical study’s full potential. By servicing our global Pharmaceutical, Biotech and Generic clients who perform Phase I, II-IV clinical trials, our goal is to exceed their expectations by offering outstanding monitoring, project management and clinical operation services.